Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Richard N. Ingram is active.

Publication


Featured researches published by Richard N. Ingram.


Journal of Molecular Biology | 2008

Crystal structures of the pro-inflammatory cytokine interleukin-23 and its complex with a high-affinity neutralizing antibody

Brian M. Beyer; Richard N. Ingram; Lata Ramanathan; Paul Reichert; Hung V. Le; Vincent Madison; Peter Orth

Interleukin (IL)-23 is a pro-inflammatory cytokine playing a key role in the pathogenesis of several autoimmune and inflammatory diseases. We have determined the crystal structures of the heterodimeric p19-p40 IL-23 and its complex with the Fab (antigen-binding fragment) of a neutralizing antibody at 2.9 and 1.9 A, respectively. The IL-23 structure closely resembles that of IL-12. They share the common p40 subunit, and IL-23 p19 overlaps well with IL-12 p35. Along the hydrophilic heterodimeric interface, fewer charged residues are involved for IL-23 compared with IL-12. The binding site of the Fab is located exclusively on the p19 subunit, and comparison with published cytokine-receptor structures suggests that it overlaps with the IL-23 receptor binding site.


Journal of Synchrotron Radiation | 2008

Key steps in the structure-based optimization of the hepatitis C virus NS3/4A protease inhibitor SCH503034

Vincent Madison; Andrew Prongay; Zhuyan Guo; Nanhua Yao; John Pichardo; Thierry O. Fischmann; Corey Strickland; Joseph E. Myers; Patricia C. Weber; Brian M. Beyer; Richard N. Ingram; Zhi Hong; Winifred W. Prosise; Lata Ramanathan; S. Shane Taremi; Taisa Yarosh-Tomaine; Rumin Zhang; Mary M. Senior; Rong-Sheng Yang; Bruce A. Malcolm; Ashok Arasappan; Frank Bennett; Stephane L. Bogen; Kevin X. Chen; Edwin Jao; Yi-Tsung Liu; Raymond G. Lovey; Anil K. Saksena; Srikanth Venkatraman; Viyyoor M. Girijavallabhan

Crystal structures of protease/inhibitor complexes guided optimization of the buried nonpolar surface area thereby maximizing hydrophobic binding. The resulting potent tripeptide inhibitor is in clinical trials.


Archive | 2008

Engineered anti-IL-23p19 antibodies

Leonard G. Presta; Brian M. Beyer; Richard N. Ingram; Peter Orth; Yan-Hui Liu


Analytical Biochemistry | 1999

A continuous spectrophotometric assay for the hepatitis C virus serine protease.

Rumin Zhang; Brian M. Beyer; James Durkin; Richard N. Ingram; F. George Njoroge; William T. Windsor; Bruce A. Malcolm


Journal of Medicinal Chemistry | 2007

Discovery of the HCV NS3/4A protease inhibitor (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (Sch 503034) II. Key steps in structure-based optimization.

Andrew Prongay; Zhuyan Guo; Nanhua Yao; John Pichardo; Thierry O. Fischmann; Corey Strickland; Joseph E. Myers; Patricia C. Weber; Brian M. Beyer; Richard N. Ingram; Zhi Hong; Winifred W. Prosise; Lata Ramanathan; S. Shane Taremi; Taisa Yarosh-Tomaine; Rumin Zhang; Mary M. Senior; Rong-Sheng Yang; Bruce A. Malcolm; Ashok Arasappan; Frank Bennett; Stephane L. Bogen; Kevin Chen; Edwin Jao; Yi-Tsung Liu; Raymond G. Lovey; Anil K. Saksena; Srikanth Venkatraman; Viyyoor M. Girijavallabhan; F. George Njoroge


Journal of Molecular Biology | 2004

Crystal Structure of the Catalytic Domain of Human ADAM33

Peter Orth; Paul Reichert; Wenyan Wang; Winifred W. Prosise; Taisa Yarosh-Tomaine; Gerald Hammond; Richard N. Ingram; Li Xiao; Urooj A. Mirza; Jun Zou; Corey Strickland; S. Shane Taremi; Hung V. Le; Vincent Madison


Biochemistry | 1998

Serine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex

D. Šali; Richard N. Ingram; Michele Wendel; Divya Gupta; Charles McNemar; Anthony Tsarbopoulos; Janice W. Chen; Zhi Hong; Robert Chase; Christine Risano; Rumin Zhang; Nanhua Yao; Ann D. Kwong; Lata Ramanathan; Hung V. Le; Patricia C. Weber


Virology | 1996

Enhancement of Hepatitis C Virus NS3 Proteinase Activity by Association with NS4A-Specific Synthetic Peptides: Identification of Sequence and Critical Residues of NS4A for the Cofactor Activity

Nancy Butkiewicz; Michelle Wendel; Rumin Zhang; Ronald G. Jubin; John Pichardo; Elizabeth B. Smith; Andrea Hart; Richard N. Ingram; James Durkin; Philip W. Mui; Michael G. Murray; Lata Ramanathan; Bimalendu Dasmahapatra


Bioorganic & Medicinal Chemistry Letters | 2005

Hepatitis C virus NS3-4A serine protease inhibitors: SAR of P2′ moiety with improved potency

Ashok Arasappan; F.G. Njoroge; Tin-Yau Chan; Frank Bennett; Stephane L. Bogen; Kevin X. Chen; Haining Gu; Liwu Hong; Edwin Jao; Y.T. Liu; Raymond G. Lovey; Tejal N. Parekh; Russell E. Pike; Patrick A. Pinto; B. Santhanam; Srikanth Venkatraman; Henry A. Vaccaro; Hongwu Wang; Xiaozheng Yang; Zhaoning Zhu; Brian Mckittrick; Anil K. Saksena; Viyyoor M. Girijavallabhan; John Pichardo; Nancy Butkiewicz; Richard N. Ingram; B. Malcolm; Andrew Prongay; Nanhua Yao; B. Marten


Archives of Biochemistry and Biophysics | 2006

IK682, a tight binding inhibitor of TACE.

Xiaoda Niu; Shelby P. Umland; Richard N. Ingram; Brian M. Beyer; Yan-Hui Liu; Jing Sun; Daniel Lundell; Peter Orth

Collaboration


Dive into the Richard N. Ingram's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge